OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
November 20, 2019
Trends affecting primary pharmaceutical packaging include the shift to more complex drug-device combination products.
October 03, 2019
The contraceptive is expected to receive new chemical entity designation from FDA, giving it patent protection beyond 2030. It will be launched in early 2021, pending FDA approval.
June 20, 2019
The company has expanded its high-potency API capability at its Riverview, MI, facility to serve the growing antibody drug conjugates market.
June 02, 2019
A simple, one-part DPI aims to make inhalation drug treatment more accessible and affordable.
August 01, 2018
API can be mixed with silicone and other polymers to create drug-delivery combination products.
June 13, 2017
Aptar now manufactures its child-resistant pump, designed to meet US CPC requirements, at its facility in Congers, New York.
May 02, 2017
Recent legislation and PDUFA initiatives aim to streamline oversight and testing requirements.
February 23, 2017
The authors discuss regulatory and patent issues with combination products.
November 09, 2016
PMMI, The Association for Packaging and Processing Technologies, released a report on trends opportunities in packaging of pharmaceuticals and medical devices that predicts increased spending on capital equipment for processing and packaging.
September 21, 2016
Mylan CEO Heather Bresch appeared before the House Committee on Oversight and Government Reform on Sept. 21, 2016 to explain the company’s decision to increase the price of EpiPen more than 400%. The meeting comes after multiple members of Congress raised concerns about the price of the life-saving drug, which is used to treat anaphylaxis.